Hemispherx Videos

Hemispherx (NYSE:HEB) Starting Two New Clinical Trials at Major US Cancer...

In this episode of CEO Roadshow, we’re joined by Mr. Thomas Equels, CEO of Hemispherx Biopharma, an immuno-pharma R&D and emerging commercial growth company...

Hemispherx News

Hemispherx Biopharma Announces Commencement of a New 45 Subject Clinical Trial...

OCALA, Fla., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma company focused on unmet medical needs in immunology...

Hemispherx Biopharma Announces Key Dates and Timeline for Stockholder Participation in...

OCALA, Fla., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) (“Hemispherx” or the “Company”), an immuno-pharma R&D and emerging commercial...

Hemispherx Articles

Hemispherx Bio up 22% on Ampligen + Keytruda studies: SeekingAlpha

Thinly traded nano cap Hemispherx Biopharma (HEB +22.1%) is up on a 7x surge in volume in reaction to its announcement of two clinical...